Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Autologous Cells Derived From Different Sources and Administered Using Different Regimens for 'no‐option' Critical Lower Limb Ischaemia Patients." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Fluoxetine_for_adults_who_are_overweight_or_obese_New. Accessed 24 April 2024.
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Fluoxetine_for_adults_who_are_overweight_or_obese_New. Accessed April 24, 2024.
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Fluoxetine_for_adults_who_are_overweight_or_obese_New
Autologous Cells Derived From Different Sources and Administered Using Different Regimens for 'no‐option' Critical Lower Limb Ischaemia Patients [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Fluoxetine_for_adults_who_are_overweight_or_obese_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
ID - 439237
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Fluoxetine_for_adults_who_are_overweight_or_obese_New
DB - Evidence Central
DP - Unbound Medicine
ER -